| 前收市價 | 35.43 |
| 開市 | 35.48 |
| 買盤 | 0.00 x 800 |
| 賣出價 | 35.90 x 1200 |
| 今日波幅 | 35.12 - 35.58 |
| 52 週波幅 | 31.01 - 50.21 |
| 成交量 | |
| 平均成交量 | 3,821,300 |
| 市值 | 17.922B |
| Beta 值 (5 年，每月) | 0.64 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.08 |
| 業績公佈日 | 2024年7月25日 - 2024年7月29日 |
| 遠期股息及收益率 | 1.16 (3.30%) |
| 除息日 | 2024年5月31日 |
| 1 年預測目標價 | 43.83 |
ZacksBaxter's (BAX) Clinolipid Gets FDA's Expanded Indication
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Insider MonkeyBaxter International Inc. (NYSE:BAX) Q1 2024 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) Q1 2024 Earnings Call Transcript May 2, 2024 Baxter International Inc. beats earnings expectations. Reported EPS is $0.65, expectations were $0.61. Baxter International Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]
